Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 14, 2013 (May 14, 2013)

 

 

U.S. PHYSICAL THERAPY, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   1-11151   76-0364866

(State or other jurisdiction of

incorporation or organization)

  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

1300 West Sam Houston Parkway South,

Suite 300, Houston, Texas

  77042
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (713) 297-7000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders (the “Annual Meeting”) of U. S. Physical Therapy, Inc. (the “Company”) was held on May 14, 2013. At the Annual Meeting, the Company’s stockholders approved the four proposals, one of which is non-binding, which are described in detail in the Company’s definitive proxy statement dated April 8, 2013 (“Definitive Proxy”). Abstentions and broker non-votes were counted for purposes of determining whether a quorum was present.

The results are as follows:

Proposal 1 – Election of ten directors to serve until the next annual meeting of stockholders.

 

Nominees

   Votes For      Votes
Withheld
     Broker
Non-Votes
 

Jerald L. Pullins

     10,399,960         40,101         979,221   

Christopher J. Reading

     10,174,910         265,151         979,221   

Lawrance W. McAfee

     9,623,105         816,956         979,221   

Daniel C. Arnold

     10,178,133         261,928         979,221   

Mark J. Brookner

     10,179,083         260,978         979,221   

Harry S. Chapman

     10,404,180         35,881         979,221   

Bernard A. Harris, Jr

     10,404,180         35,881         979,221   

Marlin W. Johnston

     10,178,133         261,928         979,221   

Regg E. Swanson

     10,176,118         263,943         979,221   

Clayton K. Trier

     10,403,980         36,081         979,221   

Proposal 2 – Advisory vote to approve named executive officer compensation.

 

Votes For

   Votes
Against
     Votes
Abstaining
     Broker
Non-Votes
 

10,336,278

     98,944         4,839         979,221   

Proposal 3 – Approval of an amendment to the Amended and Restated 2003 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance under such plan from 1,250,000 to 1,750,000 and to amend the definition of “change of control” (the “Amendment”).

 

Votes For

   Votes
Against
     Votes
Abstaining
     Broker
Non-Votes
 

9,712,185

     724,813         3,063         979,221   

Proposal 4 – Ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2013.

 

Votes For

   Votes
Against
     Votes
Abstaining
 

11,079,874

     336,620         2,788   


With respect to the election of directors and approval of the Amendment, broker non-votes were not treated as a vote for or against any particular nominee or the Amendment and did not affect the outcome of the election of directors or the approval of the Amendment. With respect to the advisory vote to approve named executive officer compensation, broker non-votes did not have any effect on the outcome of the vote.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    U.S. PHYSICAL THERAPY, INC.

Dated: May 14, 2013

    By:    /s/ LAWRANCE W. MCAFEE
    Lawrance W. McAfee
    Chief Financial Officer
   

(duly authorized officer and principal financial

and accounting officer)